RORY B RIGGS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RORY B RIGGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RORY B RIGGS. RORY B RIGGS is Director in FIBROGEN INC ($FGEN) and Director in Intra-Cellular Therapies, Inc. ($ITCI) and Director in Royalty Pharma plc ($RPRX).
Latest Insider Trading Transactions of RORY B RIGGS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FGEN, ITCI, RPRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 20.86 | 7,800 | 162,708 | 7,800 | |
| May 28 2021 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Grant | A | 0.00 | 4,700 | 0 | 395,750 | 391.1 K to 395.8 K (+1.20 %) |
| May 11 2021 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 235,519 | 0 | 0 | |
| May 11 2021 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 67,976 | 0 | 541,751 | |
| May 11 2021 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Buy | C | 0.00 | 2,355,190 | 0 | 2,355,190 | 0 to 2.4 M |
| May 11 2021 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Buy | C | 0.00 | 679,760 | 0 | 679,760 | 0 to 679.8 K |
| Apr 02 2021 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 33.93 | 464 | 15,744 | 61,941 | 61.5 K to 61.9 K (+0.75 %) |
| Oct 22 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 46,320 | 0 | 191,681 | |
| Oct 22 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 46,320 | 0 | 191,681 | |
| Oct 22 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Sell | S | 42.00 | 463,200 | 19,454,400 | 0 | 463.2 K to 0 (-100.00 %) |
| Oct 22 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Sell | S | 42.00 | 463,200 | 19,454,400 | 0 | 463.2 K to 0 (-100.00 %) |
| Oct 22 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Buy | C | 0.00 | 463,200 | 0 | 463,200 | 0 to 463.2 K |
| Oct 22 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Buy | C | 0.00 | 463,200 | 0 | 463,200 | 0 to 463.2 K |
| Jul 02 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 25.67 | 613 | 15,736 | 60,369 | 59.8 K to 60.4 K (+1.03 %) |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | M | 0.00 | 14,005 | 0 | 0 | |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | M | 0.00 | 14,005 | 0 | 59,756 | 45.8 K to 59.8 K (+30.61 %) |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | M | 0.00 | 14,005 | 0 | 0 | |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | M | 0.00 | 14,005 | 0 | 59,756 | 45.8 K to 59.8 K (+30.61 %) |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 119,982 | 0 | 119,982 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 494,485 | 0 | 494,485 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 253,889 | 0 | 253,889 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 435,267 | 0 | 435,267 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 238,001 | 0 | 238,001 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Buy | P | 28.00 | 15,000 | 420,000 | 15,000 | 0 to 15 K |
| Jun 08 2020 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
| Jun 08 2020 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Grant | A | 0.00 | 4,700 | 0 | 391,050 | 386.4 K to 391.1 K (+1.22 %) |
| May 28 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 13,767 | 0 | 13,767 | |
| Apr 02 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 15.37 | 1,024 | 15,739 | 45,751 | 44.7 K to 45.8 K (+2.29 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 34.31 | 422 | 14,479 | 44,727 | 44.3 K to 44.7 K (+0.95 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 34.31 | 422 | 14,479 | 44,727 | 44.3 K to 44.7 K (+0.95 %) |
| Oct 02 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 7.47 | 1,941 | 14,499 | 44,305 | 42.4 K to 44.3 K (+4.58 %) |
| Jun 26 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 14,005 | 0 | 14,005 | |
| Jun 07 2019 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 39.03 | 7,800 | 304,434 | 7,800 | |
| Jun 07 2019 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Grant | A | 0.00 | 4,700 | 0 | 386,350 | 381.7 K to 386.4 K (+1.23 %) |
| Apr 02 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 12.18 | 1,190 | 14,494 | 41,247 | 40.1 K to 41.2 K (+2.97 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 11.39 | 1,273 | 14,499 | 40,057 | 38.8 K to 40.1 K (+3.28 %) |
| Oct 02 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 21.70 | 668 | 14,496 | 38,784 | 38.1 K to 38.8 K (+1.75 %) |
| Sep 28 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Gift | G | 0.00 | 1,250 | 0 | 381,650 | 382.9 K to 381.7 K (-0.33 %) |
| Jul 03 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 17.67 | 820 | 14,489 | 38,116 | 37.3 K to 38.1 K (+2.20 %) |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 14,189 | 0 | 14,189 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Grant | A | 0.00 | 3,700 | 0 | 382,900 | 379.2 K to 382.9 K (+0.98 %) |
| Apr 03 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 21.05 | 688 | 14,482 | 37,296 | 36.6 K to 37.3 K (+1.88 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 55.19 | 2,618 | 144,487 | 379,200 | 381.8 K to 379.2 K (-0.69 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 54.90 | 4,382 | 240,572 | 381,818 | 386.2 K to 381.8 K (-1.13 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 53.07 | 5,402 | 286,684 | 386,200 | 391.6 K to 386.2 K (-1.38 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 54.98 | 19,693 | 1,082,721 | 391,602 | 411.3 K to 391.6 K (-4.79 %) |
| Mar 09 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 55.75 | 22,905 | 1,276,954 | 411,295 | 434.2 K to 411.3 K (-5.28 %) |
| Jan 03 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | P | 14.48 | 1,001 | 14,494 | 36,608 | 35.6 K to 36.6 K (+2.81 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 918 | 0 | 35,607 | 34.7 K to 35.6 K (+2.65 %) |
| Sep 15 2017 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 51.92 | 25,000 | 1,298,000 | 435,200 | 460.2 K to 435.2 K (-5.43 %) |
| Jun 29 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 12.45 | 20,000 | 249,000 | 20,000 | |
| Jun 09 2017 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 28.65 | 12,000 | 343,800 | 12,000 | |
| Apr 04 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 892 | 0 | 33,522 | 32.6 K to 33.5 K (+2.73 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 960 | 0 | 32,630 | 31.7 K to 32.6 K (+3.03 %) |
| Dec 16 2016 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 20.87 | 20,000 | 417,310 | 460,200 | 480.2 K to 460.2 K (-4.16 %) |
| Oct 04 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 951 | 0 | 31,670 | 30.7 K to 31.7 K (+3.10 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 373 | 0 | 30,719 | 30.3 K to 30.7 K (+1.23 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 373 | 0 | 30,719 | 30.3 K to 30.7 K (+1.23 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 373 | 0 | 30,719 | 30.3 K to 30.7 K (+1.23 %) |
| Jun 15 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 38.35 | 20,000 | 767,000 | 20,000 | |
| Jun 10 2016 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
| Apr 04 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 382 | 0 | 16,061 | 15.7 K to 16.1 K (+2.44 %) |
| Jan 05 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 53.79 | 197 | 10,597 | 15,679 | 15.5 K to 15.7 K (+1.27 %) |
| Oct 02 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 265 | 0 | 15,482 | 15.2 K to 15.5 K (+1.74 %) |
| Sep 15 2015 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 27.56 | 25,571 | 704,737 | 480,200 | 505.8 K to 480.2 K (-5.06 %) |
| Sep 15 2015 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 29.52 | 100 | 2,952 | 505,771 | 505.9 K to 505.8 K (-0.02 %) |
| Sep 15 2015 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 28.13 | 4,329 | 121,775 | 505,871 | 510.2 K to 505.9 K (-0.85 %) |
| Sep 15 2015 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 27.56 | 20,000 | 551,200 | 510,200 | 530.2 K to 510.2 K (-3.77 %) |
| Jul 02 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 332 | 0 | 15,217 | 14.9 K to 15.2 K (+2.23 %) |
| Jun 22 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 26.58 | 20,000 | 531,600 | 20,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 444 | 0 | 14,885 | 14.4 K to 14.9 K (+3.07 %) |
| Jan 05 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 601 | 0 | 14,441 | 13.8 K to 14.4 K (+4.34 %) |
| Oct 02 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 774 | 0 | 13,840 | 13.1 K to 13.8 K (+5.92 %) |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 16.86 | 20,000 | 337,200 | 20,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 1,260 | 0 | 13,066 | 11.8 K to 13.1 K (+10.67 %) |
| Mar 24 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 18.56 | 20,000 | 371,200 | 20,000 | |
| Feb 05 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | P | 17.50 | 28,571 | 499,993 | 240,955 | 212.4 K to 241 K (+13.45 %) |
Page: 1